Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |